News
In a decision filed March 28, Hon. Steven C. Seeger granted The Lansing Journal’s motion to dismiss the lawsuit filed by Lan-Oak Park District ...
Merck on Thursday said its first-quarter adjusted profit rose 7% as lower costs helped offset a 2% decline in sales, ...
On a per-share basis, the Rahway, New Jersey-based company said it had profit of $2.01. Earnings, adjusted for one-time gains and costs, came to $2.22 per share. The results exceeded Wall Street ...
Max is trading its bright blue branding and logo for a black-and-white color palette that evokes HBO’s classic branding.
Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that ...
I initiate coverage on Merck & Co., Inc. with a Strong Buy rating and a $139 price target, driven by resilient execution and robust product depth. Merck is growing pharma sales and expanding ...
NEW YORK, March 27 (Reuters) - Merck & Co (MRK.N), opens new tab said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy Keytruda in the ...
While one theory traces the Vikings’ name and colors to Wisconsin, it’s not the definitive explanation. The Vikings’ original helmet, uniform and logo were designed by Los Angeles cartoonist ...
Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or Pneumococcal 21-valent Conjugate Vaccine, for active ...
A Merck logo is shown on a scientist's lab coat. The Food and Drug Administration, on Sept. 4, 2014, granted accelerated approval to Merck's Keytruda for treating melanoma that has spread or can't be ...
Max, the Warner Bros. Discovery streaming service, launched a new black-and-white color palette that evokes the same aesthetics of HBO.
Guggenheim analyst Vamil Divan maintained a Buy rating on Merck & Company (MRK – Research Report) today and set a price target of $115.00. Discover outperforming stocks and invest smarter with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results